The US pabulum and Drug Administra...

The US pabulum and Drug Administration has approved a fresh medication, the first new anti-malaria issue available in 11 years, according to a July 17 2000 stranges release from NewsEdge Corp. The medication combines an agent used to treat lung infections in immune-compromised patients and an older malaria therapy. Malaria, a parasitic infection, is contracted by the agency of more than 300 million tribe each year and kills approximately 27 million. The disease is rare in lay opened countries due to medication and insecticide, moreover it runs rampant in tropical, developing countries.

Symptoms of malaria include agitation chills, headache, muscle aches, and malaise. Individuals who become ill after visiting the tropics should confer a physician immediately and must be enduring to mention their trip. Another alternative is to visit a physician before traveling to the tropics to discuss prevention methods

Four clinical trials using the medication were directioned in Africa. Of 279 clan using the medication for three month solely two developed malaria. In comparison, 92 population of 297 using a placebo contracted malaria. Side validitys of the medication include headache, abdominal pain, and vomiting.

FDA Approves Malaria remedy (news release, Washington, DC: NewsEdge Corp, July 17 2000) 1-2 Available from http://www.individual.com/fr.../story.shtml?story=h071410 7.700&level13=552&date=2000071. Accessed 17 July 2000

COPYRIGHT 2001 Association of Operating swing Nurses, Inc.

COPYRIGHT 2001 Gale Group